Product Information
VERAPAMIL ER PM 300 MG CAPSULE is a generic product labeled by Lannett Company Inc., priced at $8.0273 per EA under NDC 62175048737. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
300 mg/1
Manufacturer
Lannett Company Inc.NDC
62175048737
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020943On Market Since
11/25/1998
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL ER PM 300 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 327.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.0273 per EA |
|---|---|
| All-time high | $8.9342 (Jan 12, 2022) |
| All-time low | $1.4464 (Oct 17, 2018) |
| 52-week high | $8.0429 |
| 52-week low | $7.5962 |
| Median price | $6.7359 |
| Average price | $5.1733 |
| Largest weekly change | +271.3% (Apr 17, 2019) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VERAPAMIL ER PM 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL ER PM 300 MG CAPSULE, manufactured by Lannett Company Inc., is $8.0273 per EA (NDC 62175048737), effective Jun 24, 2026.
How has the price of VERAPAMIL ER PM 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VERAPAMIL ER PM 300 MG CAPSULE has risen 327.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VERAPAMIL ER PM 300 MG CAPSULE?
Since Nov 28, 2013, the NADAC for VERAPAMIL ER PM 300 MG CAPSULE has ranged from a low of $1.4464 (Oct 17, 2018) to a high of $8.9342 (Jan 12, 2022), with a median of $6.7359 per EA.
Are there cheaper alternatives to VERAPAMIL ER PM 300 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as VERAPAMIL ER PM 300 MG CAPSULE, but none are currently priced below it.
Who manufactures VERAPAMIL ER PM 300 MG CAPSULE?
VERAPAMIL ER PM 300 MG CAPSULE (NDC 62175048737) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification